Inventor · disambiguated record
Roberto Polakiewicz
Also filed as: POLAKIEWICZ ROBERTO · POLAKIEWICZ ROBERTO D
15 granted patents·20 pending applications·20 citations·filing 2003–2020
89Inventor score
Files withCELL SIGNALING TECHNOLOGY INC23POLAKIEWICZ ROBERTO3BLUEFIN BIOMEDICINE INC1CELL SIGNALING TECHNOLGY INC1CELL SIGNALING TECHNOLOGY1
Top patents by PatentIndex Score
35 records- 0188US10036756B2Mass spectrometry analysis of mutant polypeptides in biological samplesCELL SIGNALING TECHNOLOGY INC·Filed 2016·Granted Jul 31, 2018·3 cites·16 claims
- 0282US10670606B2Mass spectrometry analysis of mutant polypeptides in biological samplesCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Jun 2, 2020·1 cites·20 claims
- 0379US9453845B2Mass spectroscopy analysis of mutant polypeptides in biological samplesMORITZ ALBRECHT·Filed 2011·Granted Sep 27, 2016·5 cites·26 claims
- 0478US10208125B2Anti-mucin 1 binding agents and uses thereofBLUEFIN BIOMEDICINE INC·Filed 2014·Granted Feb 19, 2019·4 cites·44 claims
- 0572US7973134B2Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2006·Granted Jul 5, 2011·1 cites·3 claims
- 0671US11428696B2Mass spectrometry analysis of mutant polypeptides in biological samplesCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Aug 30, 2022·0 cites·19 claims
- 0770US8466160B2Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alphaRIKOVA KLARISA·Filed 2010·Granted Jun 18, 2013·1 cites·10 claims
- 0869US7932044B2Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-αCELL SIGNALING TECHNOLOGY INC·Filed 2005·Granted Apr 26, 2011·2 cites·13 claims
- 0962US7935790B2Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathwaysCELL SINGALING TECHNOLOGY INC·Filed 2006·Granted May 3, 2011·2 cites·6 claims
- 1062US2021079445A1Multi Component DetectionCELL SIGNALING TECHNOLOGY INC·Filed 2020·Application pending·0 cites
- 1160US9588110B2Multi component antibody based detection technologyHUYNH KHANH DUC·Filed 2012·Granted Mar 7, 2017·1 cites·21 claims
- 1260US2016193208A1Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-alphaCELL SIGNALING TECHNOLOGY INC·Filed 2015·Application pending·0 cites
- 1359US2013266965A1Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-ALPHACELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 1459US2011045534A1Nucleic Acid Cassette For Producing Recombinant AntibodiesCELL SIGNALING TECHNOLOGY INC·Filed 2009·Application pending·0 cites
- 1558US10577640B2Multi component detectionCELL SIGNALING TECHNOLOGY INC·Filed 2017·Granted Mar 3, 2020·0 cites·29 claims
- 1658US7731964B2Antibodies specific for phosphorylated insulin receptor substrate-1/2 (Ser1101/Ser1149) and uses thereofCELL SIGNALING TECHNOLOGY INC·Filed 2003·Granted Jun 8, 2010·0 cites·22 claims
- 1753US7888480B2Reagents for the detection of protein phosphorylation in leukemia signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2008·Granted Feb 15, 2011·0 cites·4 claims
- 1852US2009099340A1Reagents for the detection of protein phosphorylation in carcinoma signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2007·Application pending·0 cites
- 1951US7939636B2Reagents for the detection of protein phosphorylation in c-Src signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2006·Granted May 10, 2011·0 cites·3 claims
- 2049US2019002532A1Methods and reagents for creating monoclonal antibodiesCELL SIGNALING TECHNOLOGY INC·Filed 2018·Application pending·0 cites
- 2148US2011130547A1Reagents For The Detection Of Protein Phosphorylation In EGFR Signaling PathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2010·Application pending·0 cites
- 2247US2011105732A1Reagents for the Detection of Protein Phosphorylation in Carcinoma Signaling PathwaysCELL SIGNALING TECHNOLOGY·Filed 2011·Application pending·0 cites
- 2346US2009220991A1Reagents for the detection of protein phosphorylation in leukemia signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2008·Application pending·0 cites
- 2446US2009142777A1Reagents for the detection of protein phosphorylation in leukemia signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2007·Application pending·0 cites
- 2545US2010093008A1Phospho-specific antibodies to flt3 (tyr969) and uses thereofCELL SIGNALING TECHNOLOGY INC·Filed 2007·Application pending·0 cites
- 2644US2012149880A1Nucleic Acid Cassette For Producing Recombinant AntibodiesCHEUNG WAN CHEUNG·Filed 2010·Application pending·0 cites
- 2744US2009285796A1Mutant jak3 kinase in human leukemiaCELL SIGNALING TECHNOLOGY INC·Filed 2007·Application pending·0 cites
- 2844US2009258442A1Reagents for the detection of protein phosphorylation in carcinoma signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2008·Application pending·0 cites
- 2943US2015110794A1Anti-Human Cytomegalovirus Antibodies And Use ThereofCELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 3042US9920110B2Methods and reagents for creating monoclonal antibodiesPOLAKIEWICZ ROBERTO·Filed 2012·Granted Mar 20, 2018·0 cites·32 claims
- 3142US2010151495A9Reagents for the detection of protein phosphorylation in carcinoma signaling pathwaysCELL SIGNALING TECHNOLGY INC·Filed 2008·Application pending·0 cites
- 3242US2010173322A1Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2008·Application pending·0 cites
- 3339US2009203034A1Reagents for the detection of tyrosine phosphorylation in brain ischemia signaling pathwaysGUO AILAN·Filed 2007·Application pending·0 cites
- 3438US2009298093A1Reagents for the Detection of Protein Phosphorylation in ATM & ATR Kinase Signaling PathwaysPOLAKIEWICZ ROBERTO·Filed 2007·Application pending·0 cites
- 3536US2009263832A1Reagents for the Detection of Protein Phosphorylation in Leukemia Signaling PathwaysPOLAKIEWICZ ROBERTO·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roberto Polakiewicz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →